These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 16006954

  • 1. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
    Kamel MH, Mohan P, Little DM, Awan A, Hickey DP.
    J Urol; 2005 Aug; 174(2):703-7. PubMed ID: 16006954
    [Abstract] [Full Text] [Related]

  • 2. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
    Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Osama Gaber A.
    Clin Transplant; 2011 Aug; 25(3):E250-6. PubMed ID: 21231963
    [Abstract] [Full Text] [Related]

  • 3. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
    Copeland JG, Icenogle TB, Williams RJ, Rosado LJ, Butman SM, Vasu MA, Sethi GK, McDonald AN, Klees E, Rhenman MJ.
    J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
    [Abstract] [Full Text] [Related]

  • 4. Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft thrombosis.
    Kamel MH, Mohan P, Conlon PJ, Little DM, O'Kelly P, Hickey DP.
    Pediatr Transplant; 2006 Nov; 10(7):816-21. PubMed ID: 17032428
    [Abstract] [Full Text] [Related]

  • 5. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

  • 6. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ, Duhart BT, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO.
    Transplantation; 2008 Jul 27; 86(2):313-20. PubMed ID: 18645496
    [Abstract] [Full Text] [Related]

  • 7. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 8. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT, Collins CD, Stuckey LJ, Luan FL, Englesbe MJ, Magee JC, Park JM.
    Pharmacotherapy; 2009 Oct 27; 29(10):1166-74. PubMed ID: 19792990
    [Abstract] [Full Text] [Related]

  • 9. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May 27; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 10. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M, Durrbach A, Hiesse C, Ladouceur M, Benoit G, Charpentier B.
    Transplantation; 2008 Dec 27; 86(12):1732-7. PubMed ID: 19104413
    [Abstract] [Full Text] [Related]

  • 11. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
    Martins L, Fonseca I, Almeida M, Henriques AC, Dias L, Sarmento AM, Cabrita A.
    Transplant Proc; 2005 Sep 27; 37(6):2755-8. PubMed ID: 16182802
    [Abstract] [Full Text] [Related]

  • 13. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 27; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 14. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation.
    Di Filippo S, Boissonnat P, Sassolas F, Robin J, Ninet J, Champsaur G, Bozio A.
    Transplantation; 2003 Feb 15; 75(3):354-8. PubMed ID: 12589158
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP, Cantarovich D, Le Mauff B, Giral M, Robillard N, Hourmant M, Hirn M, Jacques Y.
    N Engl J Med; 1990 Apr 26; 322(17):1175-82. PubMed ID: 2157982
    [Abstract] [Full Text] [Related]

  • 16. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, Rigley TH, Nielsen KJ, Henning ME, Skorupa JY, Skorupa AJ, Christensen KA, Sandoz JP, Kellogg AM, Langnas AN, Wrenshall LE.
    Transplantation; 2008 May 27; 85(10):1391-9. PubMed ID: 18497677
    [Abstract] [Full Text] [Related]

  • 17. Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety.
    Esposito L, Kamar N, Durand D, Rostaing L.
    Transplant Proc; 2005 Mar 27; 37(2):892-4. PubMed ID: 15848567
    [Abstract] [Full Text] [Related]

  • 18. Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients.
    Hardinger KL, Brennan DC, Schnitzler MA.
    Transplantation; 2009 May 15; 87(9):1372-6. PubMed ID: 19424038
    [Abstract] [Full Text] [Related]

  • 19. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.
    Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O.
    Transplant Proc; 2011 Mar 15; 43(2):466-8. PubMed ID: 21440735
    [Abstract] [Full Text] [Related]

  • 20. Pediatric renal transplantation: comparative study with renal transplantation in the adult population.
    Parada B, Figueiredo A, Nunes P, Bastos C, Macário F, Roseiro A, Dias V, Rolo F, Mota A.
    Transplant Proc; 2005 Mar 15; 37(6):2771-4. PubMed ID: 16182806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.